Search results
BIOPHEN CS-01(38)
Chromogenic substrate for thrombin.
BIOPHEN Antithrombin LRT (anti-Xa, Liquid Reagent Technology)
Diagnosis of congenital or acquired antithrombin deficiencies.
BIOPHEN Antithrombin LRT (anti-(h)-Xa, Liquid Reagent Technology)
Diagnosis of congenital or acquired antithrombin deficiencies.
BIOPHEN Antithrombin LRT (anti-(h)-Xa, Liquid Reagent Technology)
Diagnosis of congenital or acquired antithrombin deficiencies.
BIOPHEN Antithrombin 2.5 (Anti-Xa)
Diagnosis of congenital or acquired antithrombin deficiencies. Measurement of AT activity in biological milieu or purified fractions.
BIOPHEN Antithrombin (anti-IIa)
Diagnosis of congenital or acquired antithrombin deficiencies. Measurement of AT activity in biological milieu or purified fractions.
BIOPHEN Abnormal Control Plasma
Quality control plasma for the corresponding clotting or chromogenic assay.
Argatroban (Argatra®) Plasma Calibrator
Calibrating the assays of argatroban using clotting anti-IIa methods, especially when the HEMOCLOT Thrombin Inhibitors kit (ref. CK002K, CK002L) is used, with the low range protocol.
Argatroban (Argatra®) Control Plasma
Quality control of clotting assays proposed for measuring argatroban concentrations in plasma (especially ref. CK002K, CK002L).
Arachidonic Acid
Investigation of congenital (e.g., Glanzmann’s thrombasthenia, gray platelet syndrome) or acquired thrombopathy (e.g. myelodisplasic or myeloproliferative syndrome, Waldenström’s disease, multiple myeloma). Follow-up of patients treated with antiplatelet drugs such as aspirin, thienopyridines, abciximab and other NSAIDsand GPIIb/IIIa inhibitors.